Age at natural menopause and cause-specific mortality
- PMID: 16221806
- DOI: 10.1093/aje/kwi324
Age at natural menopause and cause-specific mortality
Abstract
Several studies have suggested that a young age at menopause may be associated with increased risk of all-cause mortality. Few studies have examined the influence of age at menopause on specific causes of death other than coronary heart disease. Data from a prospective cohort study of US adults were used to examine the relation between age at natural menopause and all-cause and cause-specific mortality among women who never used hormone replacement therapy, who never smoked, and who experienced natural menopause between the ages of 40 and 54 years. After 20 years of follow-up between 1982 and 2002, 23,067 deaths had occurred among 68,154 women. Results from Cox proportional hazards models showed that all-cause mortality rates were higher among women who reported that menopause occurred at age 40-44 years compared with women who reported that menopause occurred at age 50-54 years (rate ratio (RR) = 1.04, 95% confidence interval (CI): 1.00, 1.08). This increased risk was largely due to higher mortality rates from coronary heart disease (RR = 1.09, 95% CI: 1.00, 1.18), respiratory disease (RR = 1.19, 95% CI: 1.02, 1.39), genitourinary disease (RR = 1.39, 95% CI: 1.07, 1.82), and external causes (RR = 1.56, 95% CI: 1.21, 2.02). These findings suggest that mortality from other diseases, as well as coronary heart disease, may contribute to the increased mortality associated with a younger age at menopause.
Similar articles
-
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89. Res Rep Health Eff Inst. 2009. PMID: 19554969
-
Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study.Maturitas. 2007 Apr 20;56(4):411-9. doi: 10.1016/j.maturitas.2006.11.004. Epub 2006 Dec 11. Maturitas. 2007. PMID: 17161927
-
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44. doi: 10.1089/jwh.2006.15.35. J Womens Health (Larchmt). 2006. PMID: 16417416
-
Menopause and stroke and the effects of hormonal therapy.Climacteric. 2007 Oct;10 Suppl 2:27-31. doi: 10.1080/13697130701550903. Climacteric. 2007. PMID: 17882669 Review.
-
The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy.Maturitas. 2006 Jan 20;53(2):226-33. doi: 10.1016/j.maturitas.2005.04.009. Epub 2005 Jun 13. Maturitas. 2006. PMID: 15955642 Review.
Cited by
-
Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.Hum Mol Genet. 2012 Dec 1;21(23):5039-47. doi: 10.1093/hmg/dds348. Epub 2012 Aug 21. Hum Mol Genet. 2012. PMID: 22914733 Free PMC article.
-
Female-specific factors for IHD: across the reproductive lifespan.Curr Atheroscler Rep. 2015;17(2):481. doi: 10.1007/s11883-014-0481-6. Curr Atheroscler Rep. 2015. PMID: 25620277 Review.
-
DNA methylation-based age prediction and telomere length in white blood cells and cumulus cells of infertile women with normal or poor response to ovarian stimulation.Aging (Albany NY). 2018 Dec 8;10(12):3761-3773. doi: 10.18632/aging.101670. Aging (Albany NY). 2018. PMID: 30530921 Free PMC article.
-
Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease.PLoS One. 2018 Apr 19;13(4):e0195724. doi: 10.1371/journal.pone.0195724. eCollection 2018. PLoS One. 2018. PMID: 29672621 Free PMC article.
-
Interaction of Metals, Menopause and COVID-19-A Review of the Literature.Biology (Basel). 2023 Feb 22;12(3):350. doi: 10.3390/biology12030350. Biology (Basel). 2023. PMID: 36979042 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical